No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ZIMV240719C12500
- 5.90
- 0.000.00%
15min DelayClose Jul 18 15:58 ET
0.00High0.00Low
5.90Open5.90Pre Close0 Volume29 Open Interest12.50Strike Price0.00Turnover648.33%IV-13.66%PremiumJul 19, 2024Expiry Date8.81Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9423Delta0.0140Gamma2.35Leverage Ratio-0.2378Theta0.0004Rho2.22Eff Leverage0.0015Vega
Intraday
- 5D
- Daily
News
ZimVie to Report Second Quarter Financial Results on August 1, 2024
PALM BEACH GARDENS, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the second quarter 2024
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Domino's Pizza, Inc. (NYSE:DPZ) fell sharply during Thursday's session after the company reported mixed quarterly results.The company reported second-quarter FY24 sales growth of 7.1% year-
Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 150 points on Thursday.Shares of Cintas Corporation (NASDAQ:CTAS) rose during Thursday's session after the company reported better-
ZimVie Stock Rises on Reports of Advanced Sale Talks
Market Chatter: ZimVie in Advanced Acquisition Talks With Osstem
ZimVie (ZIMV) is in advanced talks with dental implant maker Osstem Implant, which has submitted a final bid to acquire ZimVie, Bloomberg News reported Thursday, citing people familiar with the
ZimVie (ZIMV.US) rose more than 14% before trading, and it is reported that South Korean dental implant manufacturer Osstem is interested in acquiring it.
According to informed sources, dental implant manufacturer Osstem Implant Co. is in deep negotiations to acquire its counterpart ZimVie, which is listed in New York.
Comments
Despite ZimVie's strong growth forecast, its low P/S ratio suggests shareholders may doubt these predictions, accepting lower selling prices. Investors anticipate future revenue volatility.
It's A Story Of Risk Vs Reward With ZimVie Inc. (NASDAQ:ZIMV)
$ZimVie(ZIMV.US$ hi guys
1
The low P/S for ZimVie suggests that market participants might be skeptical about its future revenue growth. Unless the company can improve on its top-line growth, its current P/S ratio could be an obstacle to a significant share price appreciation.
Read more